N E W S B Y T E S
Geoff Martha , Chairman and CEO , Medtronic , Christophe Weber , CEO of Takeda and Nobel Laureate Prof . Gregg Semenza . These keynote speakers span the breadth of lifesciences expertise , making BioAsia 2024 an unparalleled forum and networking opportunity .
As per Shakthi M . Nagappan , CEO of Telangana Lifesciences and BioAsia , “ BioAsia 2024 is a game-changer , attracting the world ’ s brightest life sciences minds . The participation of global CEOs and visionaries underscores BioAsia ’ s growing global influence . We are hopeful that some more influential leaders will join this already impressive line-up .” BioVoice News is one of the leading media partners for the event .
Merck announces winners of its Young Scientists Awards 2023
Merck , a leading science and technology company , has announced the winners of Merck Young Scientist Award 2023 , season 3 . Held at Bangalore , the annual awards recognize the work of young scientists who are driving positive change in the lives of millions across India through their cutting-edge research in life sciences . The third season of the Merck Young Scientist Award Program garnered an overwhelming response with over 1500 registrations from nearly 800 institutes across India , resulting in over 500 highquality applications . The committee selected 3 winners each from the biological and chemical sciences categories and 1 winner in the sustainability research category . Biological Science Winners : Dr . Harsha Bajaj , Dr . Debarka Sengupta , Dr . Saroj Kumar Nandi . Chemical Science Winners : Dr . Uttam Kumar Ghorai , Dr . Santanu Panda , Dr . Shobhna Kapoor . Sustainability Winner : Dr . John Mandal . The winners received a prize of INR 350,000 , comprising a cash award of INR 250,000 and a travel award of INR 100,000 . Additionally , 7 runner-up recipients , were awarded INR 100,000 .
Biocon Biologics successfully completes integration of Viatris ’ biosimilar business in 31 countries in Europe
Biocon Biologics has successfully completed the integration of the acquired Viatris ’ biosimilars business in 31 European countries .
50
BioVoiceNews | January / February 2024